These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 5818030)

  • 21. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle.
    Jamal SM; Bouma A; van den Broek J; Stegeman A; Chénard G; Dekker A
    Vaccine; 2008 Nov; 26(50):6317-21. PubMed ID: 18822336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the isolation and characterization of the saponin Quil A. Evaluation of its adjuvant activity, with a special reference to the application in the vaccination of cattle against foot-and-mouth disease.
    Dalsgaard
    Acta Vet Scand Suppl; 1978; (69):7-40. PubMed ID: 102135
    [No Abstract]   [Full Text] [Related]  

  • 24. [On several tests of the value of saponin used alone as an adjuvant in the preparation of foot-and-mouth disease vaccine].
    Bayramoglu O; Unlublebici N; Girard HC
    Bull Acad Vet Fr; 1967 Jun; 40(6):283-6. PubMed ID: 4305068
    [No Abstract]   [Full Text] [Related]  

  • 25. FMD and the contiguous cull.
    Clayton N
    Vet Rec; 2006 Dec; 159(23):787. PubMed ID: 17142633
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to emulsion vaccines.
    Anderson EC; Masters RC; Mowat GN
    Res Vet Sci; 1971 Jul; 12(4):342-50. PubMed ID: 5558541
    [No Abstract]   [Full Text] [Related]  

  • 27. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines.
    Hunter P
    Rev Sci Tech; 1996 Sep; 15(3):913-22. PubMed ID: 9025141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The efficacy of foot and mouth disease vaccines after long- term storage].
    Wittmann G
    Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
    [No Abstract]   [Full Text] [Related]  

  • 30. Challenge of foot-and-mouth disease vaccine on sheep.
    Oral M; Sutcu M; Bayramoglu O; Unluleblebici N; Erol N; Senturk M; Okay G; Boz C; Ilerle M; Yalim N; Girard HC
    Bull Off Int Epizoot; 1968; 69(3):497-508. PubMed ID: 5751491
    [No Abstract]   [Full Text] [Related]  

  • 31. [Specific immunoprophylaxis trials with calves against foot-and-mouth disease].
    Tekerlekov P; Uruchev K; Nikolova E; Genov I; Tsutsumanski V
    Vet Med Nauki; 1980; 17(2):28-35. PubMed ID: 6254238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Specific prophylaxis of foot-and-mouth disease].
    Kruglikov BA; Boĭko AA; F Darda PN; Alekhin RM; Nalivaĭko VG
    Veterinariia; 1978 Mar; (3):26-7. PubMed ID: 205990
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
    Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
    Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some problems of testing foot-and-mouth disease vaccines. II. Potency testing.
    Soós T
    Acta Vet Hung; 1987; 35(3):331-42. PubMed ID: 2829602
    [No Abstract]   [Full Text] [Related]  

  • 37. [Occurrence of an increased reaction to challenge infection after vaccination with aerosols of inactivated foot-and-mouth disease virus].
    Bauer K; Neukirch M
    Zentralbl Veterinarmed B; 1976 Jun; 23(5-6):374-83. PubMed ID: 961209
    [No Abstract]   [Full Text] [Related]  

  • 38. Sheep-pox vaccine prepared from formaldehyde inactivated virus adsorbed to aluminium hydroxide gel.
    Sólyom F; Perenlei L; Roith J
    Acta Microbiol Acad Sci Hung; 1982; 29(2):69-75. PubMed ID: 6291337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of foot-and-mouth disease vaccine in pigs treated with formaldehyde GOA saponin prepared with A22 foot-and-mouth virus].
    Sobko AI; Sokolov LN; Belokon IK; Prokhorov VN; Tcherniaev IA; Sidorov IV
    Bull Off Int Epizoot; 1972; 77(5):791-802. PubMed ID: 4676697
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.